Skip to main content
Veterinary Medicines

Gripork

Authorised
  • Influenza A virus, subtype H3N2, strain G (swine), Inactivated
  • Influenza A virus, subtype H3N2, strain SH (swine), Inactivated
  • Influenza A virus, subtype H1N1, strain OLL (swine), Inactivated

Product identification

Medicine name:
Gripork
Active substance:
  • Influenza A virus, subtype H3N2, strain G (swine), Inactivated
  • Influenza A virus, subtype H3N2, strain SH (swine), Inactivated
  • Influenza A virus, subtype H1N1, strain OLL (swine), Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Influenza A virus, subtype H3N2, strain G (swine), Inactivated
    50.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Influenza A virus, subtype H3N2, strain SH (swine), Inactivated
    50.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Influenza A virus, subtype H1N1, strain OLL (swine), Inactivated
    50.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 271/89DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 20/06/2023
Updated on: 26/06/2023